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Abstract 
The hepato- and nephro-protective potentials of Vernonia amygdalina ethanolic root extract was evaluated for 14 
days using standard bioassay in 45 normal male albino rats. The rats were divided into four treatment groups I – 
IV and a control group V. Groups I – IV were given 100mg.kg
-1
, 200mg.kg
-1,
 400mg.kg
-1
 and 600mg.kg
-1
 body 
weight, respectively while the control (group V) was given equal volume of feed and water.
 
The extracts were 
administered orally to the animals for 14 days. Blood samples were collected using the ocular puncture method 
before and weekly after administration to evaluate the extracts’ effects on aspartate transaminase (AST), acid 
phosphatase (ACP), alanine transaminase (ALT), alkaline phosphatase (ALP), bilirubin, creatinine and blood 
urea nitrogen (BUN) levels. The mean serum levels of the liver marker enzymes AST, ACP, ALT, ALP, total 
bilirubin and direct bilirubin ranged from 10.00±0.53 to 11.44±0.44, 31.29±0.64 to 33.14±0.56, 27.22±0.94 to 
29.67±0.37 and 37.83±0.59 to 40.57±1.02, 3.42±0.08 to 3.61±0.07 and 2.06±0.11 to 2.51±0.05 respectively. The 
mean levels of the nephrotic enzymes, creatinine and BUN also ranged from 39.87±1.79 to 43.04±1.57 and 
6.62±0.21 to 15.98±0.17 accordingly. Although no significant difference (p>0.05) was observed in the serum 
levels of the liver marker enzymes and creatinine when compared with the control, a dose and duration 
dependent significant increase (p<0.05) occurred in the BUN level. This tends to suggest that the ethanolic root 
extract of Vernonia amygdalina on a short term basis has some hepato-protective property while its nephro-
protective ability is still doubtful. 
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1. Introduction 
Despite the clamour for and availability of modern medicine in many countries, phyto-medicine or herbal 
medicine has become popular and indispensible all over the world as a result of easy accessibility, low cost and 
ancestral experience. It has been recognized as a potent tool in traditional medicines and in healthcare delivery. It 
is on record that as much as 80% of the population in the developing world depend on traditional medicines for 
primary healthcare (WHO, 1996). In view of the foregoing, ethno-botanical studies have been advocated as the 
most viable method of identifying new medicinal plants due to their high bioactive constituents. However, there 
is the growing interest to adopt systematic methodology to carefully evaluate scientific bases for the traditional 
herbal medicine so as to obviate the attendant severe undesirable side effects of synthetic drugs.  
Vernonia amygdalina, a member of the Asteraceae family, is a small mercurial shrub that grows 
widely in tropical Africa, used variously for nutritional and medicinal purposes. The macerated leaves are used 
in preparing ‘ofe olugbu’ which is a delicacy among the Igbos of south east Nigeria. Also, in many parts of West 
Africa especially, Cameroon, Ghana and Nigeria, stem and roots divested of the bark are used as chew-sticks for 
oral hygiene and management of some dental problems (Burkill, 1985).  
The plant has been reported to contain such important constituents as lipids (Ejoh et al., 2007), 
proteins and essential amino acids (Igile et al., 1994), carbohydrates (Eleyinmi et al., 2008), anti-nutrient 
substances (Nwafor and Akah, 2001; Erasto et al., 2007) and essential elements (Bonsi et al., 1995). 
Pharmacologically, the leaf extracts have been reported to possess hypoglycaemic and hypolipidaemic properties 
(Aka and Okafor, 1992; Ekpo et al., 2007), hepatoprotective effect (Ijeh and Obidoa, 2004; Iwalokun et al., 2006; 
Arhoghro et al., 2009) as well as anti-malarial properties (Abosi and Reaseroka, 2003). Vernonia 
amygdalina extracts are also reported to possess potent anti-schistosomal activity (Ogboli et al., 2000) as well as 
anti-cancer effects (Izevbigie et al., 2004; Sweeney et al., 2005; Song et al., 2005; Opata and Izevbigie, 2006; 
Yedjou et al., 2008). Studies have also shown that V. amygdalina extracts may strengthen the immune system 
through the regulation of many cytokines  (Sweeney et al., 2005).   
Studies using root extracts of V. Amygdalina in different solvents have been very limited. Desta (1994) 
and Steen-Kamp (2003) have reported of the anti-fertility potential of aqueous root extract of V. Amygdalina. 
Similarly, a decoction of the roots has been utilized by traditional healers in Nigeria in the treatment of 
convulsion and as an expectorant (Okokon and Onah, 2004). According to Igbakin and Oloyede (2009) ethanolic 
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root extract of V. Amygdalina contains hypoglycaemic, hypocholesterolaemic, hypolipidaemic and 
hypoproteinaemic bioactive components. More recently, Eyo et al. (2013) reported of a duration dependent 
effect of the aqueous root extract on the haematological profile of experimental animals. To the best of our 
knowledge there is very scanty information in literature on the hepatic and renal protective effects of V. 
amygdalina root extract. This study therefore attempts to investigate the possible hepato- and nephro-protective 
potentials that may be associated with the oral consumption of the ethanolic root extract of Vernonia amygdalina. 
 
2. Materials and Methods 
2.1 Collection, identification and preparation of plant material 
Fresh roots of Vernonia amygdalina were collected from a vegetable garden in Ozubulu in Ekwusigo Local 
Government Area of Anambra State, Nigeria. The plant materials were transported to the Department of Plant 
Science and Biotechnology, University of Nigeria, Nsukka where they were authenticated by a Plant taxonomist.  
The fresh roots were then taken to the Physiology laboratory of the Department of Zoology and Environmental 
Biology, washed in clean tap water and cut into smaller sizes. The cut roots were weighed and air-dried for three 
weeks under room temperature. The dried roots were weighed again to ascertain the appropriate moisture content 
and then ground into a coarse powder using a laboratory milling machine (Model 4; Thomas Willey, USA). 
100g of the powdered plant material was macerated in 300 ml of analytical absolute ethanol in a 
conical flask. The content was mixed thoroughly and left to stand for about 72 hours with an occasional shaking 
to increase the extraction capacity. Thereafter, the soaked substance was filtered with a muslin clothe (number 
60 mesh size) and the resulting ethanolic extract was concentrated till a slurry form was obtained under 65
0
C in a 
water bath. The solid residue referred to as the crude extract was stored in an air-tight experimental bottle in a 
refrigerator until ready for use. 
 
2.2 Procurement and management of experimental animals 
Forty-five adult male albino rats weighing between 124.3g – 134.5g were procured from the Genetics and 
Animal breeding Unit of the Department of Zoology and Environmental Biology, University of Nigeria, Nsukka. 
Approval was obtained from the Ethical Committee of the University of Nigeria, Nsukka to use the rats in 
accordance with the stipulated protocol for laboratory animal experimentation. The rats had no history of drug 
consumption and were kept in stainless wire rat cages equipped with drinkers and faecal collecting trays, in a 
clean and fly proof experimental animal house. They were fed commercial growers chick mash (18 % crude 
protein) product of Vital Feeds, Nigeria Limited and clean drinking water ad libitum during the period of 
acclimatization and experimentation. All the animals were maintained under standard laboratory conditions for 
temperature, humidity and light throughout the experiment and were allowed unhindered access to food and 
water. The faecal droppings in the tray were removed daily. 
 
2.3 Experimental Design 
The Forty-five (45) adult albino rats were randomly divided into five groups I - V of 9 rats each and housed in 
separate stainless wire rat cages. Each group was further replicated three times consisting of 3 rats each. Groups 
I – IV were orally administered daily with a 2ml syringe an aqueous solution of the V. amygdalina ethanolic root 
extract corresponding to 100mg/kg, 200mg/kg, 400mg/kg and 600mg/kg body weight dose respectively for 14 
days (Adebayo et al., 2003). Contrarily, the Control group V, was fed daily also with commercial grower’s chick 
mash and water only. 
 
2.4 Collection of Blood Sample  
About 5 ml of the blood sample was collected from each anaesthetized rat using the ocular puncture method 
(Hoff, 2000) before treatment (Day 0) and subsequently on the 7
th
 and 14
th
 days respectively. The blood samples 
were collected with heparinized haematocrit tubes and kept in ice-cold heparinized bottles.  They were allowed 
to stand for 30 minutes, centrifuged at 5000rpm for 5 minutes while the plasma samples were collected and 
stored at 20
o
C until required. 
 
2.5 Biochemical Assays 
The serum levels of the basic liver and kidney function enzymes were assayed using commercially available 
diagnostic assay kits (Randox Laboratories LTD, United Kingdom). 
The serum levels of AST and ALT were ascertained with the methodology of Reitman and Frankel 
(1957) while the ACP level was determined using the α-Naphthylphosphate kinetic method (Sood, 2006) and the 
ALP level was verified with the pNPP kinetic method (Sood, 2006). On the other hand, the total and direct 
bilirubin levels were determined using the modified Jendrassik and Grof method (Sood, 2006). 
The blood urea nitrogen (BUN) content was ascertained according to the modified Berthelot and 
Searcy method (Sood, 2006) using the formular:  
Advances in Life Science and Technology                                                                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) 
Vol 30, 2015 
 
36 
Serum BUN concentration (mg urea nitrogen/100 ml) = 
                                                                                
Similarly, the serum creatinine level was determined by employing the modified Jaffa’s kinetic method (Sood, 
2006) using the formular:  
Serum creatinine concentration (mg/dl) = 
                                                                             
2.6 Statistical Analysis  
The data obtained was analyzed using SPSS version 20.0 (IBM Statistics, UK). One-way analysis of variance 
(ANOVA) was used to test for variations of the various parameters. All results were expressed as Mean ± 
Standard error, while the level of significance was placed at p < 0.05. 
 
3. RESULTS 
3.1 The Effects of Ethanolic Root Extracts of V. amygdalina on Hepatic Enzymes and Bilirubin levels of normal 
Albino rats.  
Table 1 shows the result of the effects of the V. amygdalina ethanolic root extracts on the hepatic enzymes and 
Bilirubin serum levels. There was no significant difference (p>0.05) observed in the serum levels of the hepatic 
enzymes assayed despite the somewhat minimal wavelike but insignificant duration dependent increases 
observed in AST (400mg/kg), ACP (100mg/kg, 400mg/kg and 600mg/kg), ALT (200mg/kg – 600mg/kg), 
ALP (100mg/kg and 600mg/kg), Total bilirubin (400mg/kg and 600mg/kg) and Direct bilirubin (100mg/kg – 
600mg/kg). 
 
3.2 Effects of Ethanolic Root extracts of V. amygdalina on Nephrotic enzymes of normal Albino rats. 
Table 2 shows the result of the V. amygdalina root extract effect on the nephrotic enzymes of the albino rats. 
There was no overall dose and duration dependent significant change (p>0.05) observed in the serum creatinine 
levels of the treated rats when compared with the control group. However, a minimal wavelike but insignificant 
dose and duration dependent increase in the serum creatinine levels was observed on the 14
th
 day of treatment in 
virtually all the treatment groups. 
Contrarily, there was an overall dose and duration dependent significant increase (p<0.05) observed in 
the BUN serum levels of the treated rats in comparison with the control. It is equally noteworthy that the least 
increase in the serum BUN level was observed in the 7
th
 day of 100mg/kg dose (9.88±0.14) while the highest 
value was obtained on the 14
th
 day of the rats administered the 600mg/kg dose (15.98±0.17).  
 
4. Discussion 
Data accumulated in this study showed that the ethanolic root extract of V. amygdalina recorded no significant 
difference in the serum levels of the liver marker enzymes assayed namely, AST, ACP, ALT, ALP and Bilirubin. 
Usually the serum levels of the above enzymes have been used as a good indicator of not only the functionality 
and cellular integrity of the liver (Lavanaya et al., 2011) but as well, to assess the functional health status and the 
internal environment of the organism (Rehman et al., 2006). Normally an elevation in their serum levels may 
indicate an inflammation or damage to the hepatocytes (Sood, 2006) especially whenever the liver undergoes 
such pathological conditions as cirrhosis or subjected to abnormal onslaught that accompany the presence of 
toxins or usage of some drugs (Nyblom et al., 2004; Crook, 2006). Inflamed or injured liver cells release higher 
than normal amounts of certain chemicals, including liver enzymes into the blood stream thereby resulting in 
elevated concentration of the liver enzymes after blood tests. The fact that the extract had no significant effect on 
the serum levels of these liver marker enzymes is an indication that it had no negative interaction on the 
hepatocytes and as such did not increase the activities of the lysosomes. In addition, the extract interaction with 
the animal appeared to have not caused any damage to the mitochondria nor did it affect the membrane 
permeability of the liver cells thus, not inducing any form of liver damage nor dysfunction (Crook, 2006). 
Furthermore the dose levels of the ethanolic root extract used did not adversely interfere with the functions of the 
liver involved in such processes as calcification, metabolism, production and excretion of bilirubin (Edem and 
Usoh, 2009). Our present observation largely corroborates past findings on the hepato-protective potentials of 
various extracts of V. amygdalina in experimental animals (Ijeh and Obidoa, 2004; Iwalokun et al., 2006; 
Arhoghro et al., 2009). It also supports an earlier observation that the aqueous root extracts increases the 
formation rather than destruction of red blood cells in experimental animals (Eyo et al., 2013).  
An elevation in the serum levels of BUN and creatinine in clinical analyses presupposes renal 
dysfunction (Sood, 2006; Mehrdad et al., 2011). This informed our decision to ascertain the serum values of 
BUN and creatinine in the treated animals. The absence of a significant difference in the serum creatinine levels 
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of treated and control albino rats obtained in the present report simply indicates that the extract had no negative 
effect on the kidneys (Atangwho et al., 2007). This presupposes that the root extract did not impair the 
functioning renal tubular mass as well as its regulatory functions. Secondly, it shows that there was no form of 
abnormality in the metabolism of protein molecules in the muscles following the introduction of the root extract. 
This is more so, as creatinine is a major catabolic product of protein metabolism in the muscle tissue usually 
excreted by the kidneys (Mehrdad et al., 2011). Our opinion is strongly supported by the view of Nwangwu et al. 
(2011) who reported that ethanolic leaf extract of V. Amygdalina caused a non-significant reduction in the total 
protein content of experimental animals. Nevertheless, the observed oscillating minimal non-significant increase 
in the serum creatinine levels (Table 2) is very disturbing. We are prone to assume among other things, that such 
may be indicative of the root extract’s propensity to negatively impair renal function with increasing dosage and 
duration of usage. Or at best may be some sort of a compensatory mechanism of the kidney to ameliorate the 
effect of the ethanolic extract (Medubi et al., 2010).    
Similarly, the observed dose and duration dependent significant increase in the BUN level of the 
treated rats when compared with the control is instructional. Urea equally is the end product of protein 
metabolism which may be as a result of renal disease, urinary obstructions, shock, congestive heart failure or 
burns (Sood, 2006). Presently, it is extremely difficult to be categorical on the extract’s negative effect on renal 
function of the treated animals. We can only suspect a gradual tendency of the extract to manifest significantly 
its harmful renal tendencies (Adebayo et al., 2003). This is because, although the extract showed a dose and 
duration dependent significant increase, yet the least serum BUN level at the 7
th
 day of the rats administered 
100mg/kg (9.88±0.14mg/dL) and the highest level at the 14
th
 day of the rats that received 600mg/kg 
(15.98±0.17mg/dL) still fall within the normal BUN serum level (8 – 25mg) in humans (Ficker et al., 2003). 
Nevertheless, caution should be exercised in the prolonged usage of the ethanolic root extract of V. Amygdalina. 
This is more so as several past studies have linked the usage of high doses of plant extract with the possibility of 
toxic injury to the kidney which may result in acute renal failure (Ijeh and Ukweni, 2007). 
 
5. Conclusion 
The trend of the results obtained in the present study tends to suggest that although the ethanolic root extract of V. 
amygdalina may have some hepato-protective property, its nephro-protective ability is still doubtful. Therefore 
more studies must be carried out on the V. Amygdalina root extract using various solvents. This will go a long 
way to fully ascertain the most beneficial means of harnessing its abundant medical potentials to benefit 
mankind the more.  
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Table 1: The effects of Ethanolic root extracts of V. amygdalina on Hepatic enzymes and Bilirubin of 
normal Albino Rats.  
PARAMETERS Dosage (mg/kg)                                   Duration (Days) 
            0                                 7                             14 
AST (U/L) Control 9.67±0.78
a1
* 10.56±0.58
a1
 10.33±0.37
a1
 
100 10.11±0.74
a1
 10.78±0.72
a1
 10.44±0.44
a1
 
200 10.11±0.66
a1
 10.56±0.60
a1
 10.44±0.38
a1
 
400 10.56±0.63
a1
 11.22±0.60
a1
 11.44±0.44
a1
 
600 10.00±0.53
a1
 10.11±0.26
a1
 10.11±0.39
a1
 
ACP  (U/L) Control 31.89±0.45
a1
 31.28±0.64
a1
 31.90±0.62
a1
 
100 32.49±0.92
a1
 32.73±0.71
a1
 33.04±0.70
a1
 
200 31.31±0.49
a1
 31.29±0.64
a1
 32.73±0.50
a1
 
400 32.20±0.51
a1
 33.14±0.56
a1
 33.08±0.65
a1
 
600 31.89±0.45
a1
 32.73±0.66
a1
 32.84±0.38
a1
 
ALT  (U/L) Control 26.00±1.258
a1
 26.67±0.97
a1
 26.78±0.85
a1
 
100 27.67±0.87
a1
 27.33±0.97
a1
 29.56±0.84
a1
 
200 27.22±0.94
a1
 27.67±1.12
a1
 28.78±1.06
a1
 
400 27.33±0.67
a1
 28.11±0.75
a1
 29.00±0.58
a1
 
600 27.67±0.67
a1
 28.78±0.55
a1
 29.67±0.37
a1
 
ALP  (U/L)  Control 41.38±2.22
a1
 41.46±2.16
a1
 41.51±1.91
a1
 
100 39.84±1.11
a1
 39.81±1.08
a1
 40.57±1.02
a1
 
200 37.83±0.59
a1
 39.37±0.87
a1
 38.24±0.80
a1
 
400 39.03±0.96
a1
 38.32±0.59
a1
 39.22±0.52
a1
 
600 38.82±0.52
a1
 38.83±0.51
a1
 39.33±0.83
a1
 
Total Bilirubin 
   (g/dL) 
Control 3.34±0.13
a1
 3.41±0.12
a1
 3.39±0.10
a1
 
100 3.45±0.13
a1
 3.57±0.12
 a1
 3.47±0.06
a1
 
200 3.46±0.12
a1
 3.46±0.12
a1
 3.42±0.08
a1
 
400 3.53±0.07
a1
 3.61±0.07
a1
 3.58±0.06
a1
 
600 3.43±0.09
a1
 3.50±0.08
a1
 3.57±0.09
a1
 
Direct Bilirubin 
    (g/dL) 
Control 2.37±0.12
a1
 2.40±0.11
a1
 2.37±0.09
a1
 
100 2.17±0.11
a1
 2.28±0.14
a1
 2.38±0.11
a1
 
200 2.06±0.11
a1
 2.28±0.10
a1
 2.38±0.06
a1
 
400 2.14±0.08
a1
 2.18±0.07
a1
 2.27±0.07
a1
 
600 2.14±0.07
a1
 2.51±0.05
a1
 2.50±0.05
a1
 
*Values with different alphabetic (lower case) superscripts differ significantly (P<0.05) between different 
concentrations within the same exposure duration. Similarly, values with different numeric superscripts differ 
significantly (P<0.05) between different exposure periods within the same concentration. Results are expressed 
as Mean  
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Table 2: The effects of Ethanolic root extracts of V. amygdalina on Nephrotic enzymes of normal Albino 
Rats.  
PARAMETERS Concentrations 
(mg/kg) 
                                  Duration (Days) 
            0                                 7                              14 
Creatinine 
(mg/dL) 
Control 39.87±1.89
a1
* 40.16±1.89
a1
 38.42±1.28
a1
 
100 39.87±1.79
a1
 41.31±1.86
a1
 40.73±1.56
a1
 
200 40.16±1.89
a1
 43.04±1.57
a2
 42.76±1.44
a2
 
400 40.16±1.44
a1
 40.44±1.57
a1
 41.89±1.59
a1
 
600 40.42±1.89
a1
 41.89±1.76
a1
 42.18±1.55
a1
 
Blood Urea 
(mg/dL) 
Control 7.07±0.16
a1
 7.24±0.18
a1
 7.12±0.17
a1
 
100 6.62±0.21
a1
 9.88±0.14
b2
 13.48±0.17
b3
 
200 6.91±0.19
a1
 11.08±0.10
b2
 14.36±0.15
b3
 
400 7.14±0.17
a1
 11.32±0.14
b2
 15.04±0.17
b3
 
600 6.93±0.17
a1
 12.47±0.15
b2
 15.98±0.17
b3
 
*Values with different alphabetic (lower case) superscripts differ significantly (P<0.05) between different 
concentrations within the same exposure duration. Similarly, values with different numeric superscripts differ 
significantly (P<0.05) between different exposure periods within the same concentration. Results are expressed 
as Mean ± SEM. 
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